1. Exploring the Role of p53 in Radiosensitivity: A Key Player in Cancer Therapy
   Tusher- Al-Arafat et al, 2024, Radiation CrossRef
2. Developments in zebrafish avatars as radiotherapy sensitivity reporters — towards personalized medicine
   Bruna Costa et al, 2020, EBioMedicine CrossRef
3. Radiation-induced DNA damage response and resistance in colorectal cancer stem-like cells
   Kumari Anuja et al, 2019, International Journal of Radiation Biology CrossRef
4. Differential Radiosensitizing Effect of 50 nm Gold Nanoparticles in Two Cancer Cell Lines
   Miguel Ángel Pérez-Amor et al, 2022, Biology CrossRef
5. Systems biology and OMIC data integration to understand gastrointestinal cancers
   Iasmin Moreira Costa Bispo et al, 2022, World Journal of Clinical Oncology CrossRef
6. The impact of TP53BP1 and MLH1 on metastatic capability in cases of locally advanced prostate cancer and their usefulness in clinical practice
   Arkadiusz Gzil et al, 2020, Urologic Oncology: Seminars and Original Investigations CrossRef
7. DNA damage response and repair in colorectal cancer: Defects, regulation and therapeutic implications
   Mohammad Mirza-Aghazadeh-Attari et al, 2018, DNA Repair CrossRef
8. Assessment of γ-H2AX and 53BP1 Foci in Peripheral Blood Lymphocytes to Predict Subclinical Hematotoxicity and Response in Somatostatin Receptor-Targeted Radionuclide Therapy for Advanced Gastroenteropancreatic Neuroendocrine Tumors
   Thorsten Derlin et al, 2021, Cancers CrossRef
9. Recent Research Advances in Double-Strand Break and Mismatch Repair Defects in Prostate Cancer and Potential Clinical Applications
   Damian Jaworski et al, 2023, Cells CrossRef
10. 53BP1: A key player of DNA damage response with critical functions in cancer
    Mohammad Mirza-Aghazadeh-Attari et al, 2019, DNA Repair CrossRef
11. 53BP1 expression and immunoscore are associated with the efficacy of neoadjuvant chemoradiotherapy for rectal cancer
    Ai Huang et al, 2020, Strahlentherapie und Onkologie CrossRef
12. Individual radiosensitivity reflected by γ-H2AX and 53BP1 foci predicts outcome in PSMA-targeted radioligand therapy
    Liam Widjaja et al, 2023, European Journal of Nuclear Medicine and Molecular Imaging CrossRef
13. 53BP1 loss suppresses the radiosensitizing effect of icotinib hydrochloride in colorectal cancer cells
    Ai Huang et al, 2018, International Journal of Radiation Biology CrossRef